GP5 and prostate adenocarcinoma: However, statistically significant differences in mRNA expression between primary GP3-4 and GP5 lesions in the TCGA-PRAD dataset were noted for only two genes, SLC16A3(Fig. 6b, Supplementary Table 10) and LDHB (Fig. 6d, Supplementary Table 10).